Target intelligence / Profile preview

SARS-CoV-2 Spike Protein S1 Subunit Receptor-Binding Domain (RBD)

Target: RBD
Molecular classification: Protein Domain, Viral Protein, Receptor Binding Domain

Overview

The SARS-CoV-2 Spike Protein S1 subunit’s receptor-binding domain (RBD) is an essential molecular target mediating virus-host cell attachment via ACE2 recognition. Its structural features—disulfide bonds, glycosylation sites—and dynamic conformational states underpin both its biological function and utility as an antigenic determinant central to diagnostics, therapeutics, antibody development, and vaccine design against COVID‑19.

Other names: Spike RBDSARS-CoV-2 RBDS1-RBD

Mechanism of action

Binds to ACE2 receptor, blocking viral entry; targeted by neutralizing antibodies that prevent ACE2 binding; vaccines elicit antibody response against RBD.

Biological functions

Receptor bindingViral entryImmune recognitionAntigen presentation

Disease associations

COVID-19Infection

Safety considerations

Potential for antibody-dependent enhancement (ADE), though not definitively proven for SARS-CoV-2 RBDRisk of immune escape due to mutations in the RBD sequence

Interacting drugs

Neutralizing antibodies

2 more in the full profile.

Biomarkers

Anti-RBD antibody levels (for vaccine efficacy)RBD mutations (for variant tracking and immune evasion)

Beyond the preview

Go deeper on SARS-CoV-2 Spike Protein S1 Subunit Receptor-Binding Domain (RBD).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SARS-CoV-2 Spike Protein S1 Subunit Receptor-Binding Domain (RBD).

Explore the full profile